Ophthalytics’ AI retina screening system makes a splash at ARVO 2023

Ophthalytics stole the spotlight at ARVO 2022, the world’s largest ophthalmology conference, with groundbreaking Artificial Intelligence (AI) models. These highly accurate and adaptable solutions impressed attendees from around the globe, earning recognition for their compatibility with diverse cameras and fundus images. With a steadfast commitment to ending preventable blindness caused by Diabetic Retinopathy and a robust pipeline addressing glaucoma, AMD, ROP, and cardiovascular risks. Ophthalytics also offers data science and deep learning advisory services, providing comprehensive support to the field.

#medtech #AI #diabeticretinopathy #machinelearning #medicaldevices

Leave a Reply

Your email address will not be published. Required fields are marked *